O14818 (PSA7_HUMAN) Homo sapiens (Human)

Proteasome subunit alpha type-7 UniProtKBInterProSTRINGInteractive Modelling

248 aa; Sequence (Fasta) ; (Isoform 2; Isoform 4); 1 identical sequence: Homo sapiens: A0A0K0K1K4

Available Structures

89 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The human 26S Proteasome at 6.8 Ang.
5ln3
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		1-248
Assess
Human Constitutive 20S Proteasome
4r3o
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-244
Assess
Human constitutive 20S proteasome in complex with carfilzomib
4r67
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-244
6×3BV;
Assess
Structure of human constitutive 20S proteasome complexed with the inhibitor TDI-8304
8ud9
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-244
2×YRE;
Assess
The human 26S proteasome at 3.9 A
5l4g
 Heteromer
P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436; 		2-244
5×ATP; 5×MG; 1×ADP;
Assess
Structure of the human 26S proteasome bound to USP14-UbAl
5gjq
 Heteromer
O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-244
6×ADP;
Assess
Human 20S proteasome bound to an engineered 11S (PA26) activator
6xmj
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; Q9U8G2; 		3-244
Assess
Human 20S proteasome complex with Oprozomib at 1.9 Angstrom
5ley
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-241
58×CL; 6×K; 10×MG; 9×1PE;
Assess
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom
5lez
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-241
6×K; 10×MG; 9×1PE; 4×ACT;
Assess
Human 20S proteasome assembly intermediate structure 2
8qyl
 Heteromer
O95456; P25786; P25787; P25788; P25789; P28066; P49720; P60900; Q969U7; Q99436; Q9Y244; 		2-241
Assess
Native human 20S proteasome at 1.8 Angstrom
5le5
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
57×CL; 9×1PE; 6×K; 10×MG;
Assess
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom
5lf4
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
52×CL; 8×K; 10×MG; 9×1PE; 4×6V7;
Assess
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom
5lf1
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
56×CL; 6×K; 10×MG; 9×1PE; 6×6VC;
Assess
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom
5lf7
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
51×CL; 6×K; 10×MG; 9×1PE; 6×6V8;
Assess
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom
5lf6
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
55×CL; 6×K; 10×MG; 9×1PE; 2×PHQ;
Assess
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom
5lf3
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
51×CL; 6×K; 10×MG; 9×1PE; 6×BO2;
Assess
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom
5lex
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
6×K; 9×MG; 9×1PE;
Assess
Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom
5lf0
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
58×CL; 6×K; 10×MG; 9×1PE;
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot…
5vft
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SC_USP14
7w3j
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 2×ADP; 1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in state EA2.0_UBL
7w38
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 6×MG; 2×ADP; 1×ZN;
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot…
5vfp
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×AGS;
Assess
Human PA200-20S proteasome with MG-132
8cvs
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; 		2-240
6×LDZ; 2×IHP;
Assess
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.0_USP14
7w3g
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 1×ADP; 1×ZN;
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot…
5vfr
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×AGS;
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
6mse
 Heteromer
O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 3×ATP; 3×MG; 2×ADP;
Assess
Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot…
5vfs
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 6×AGS;
Assess
Structural basis for dynamic regulation of the human 26S proteasome
5t0h
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
6×ADP; 1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.1_USP14
7w3h
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 4×MG; 1×ADP; 1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in state EA2.1_UBL
7w39
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 5×MG; 2×ADP; 1×ZN;
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot…
5vfq
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×AGS;
Assess
Human 19S-20S proteasome, state SD2
8cvt
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 6×LDZ; 1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED4_USP14
7w3a
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
2×ADP; 4×ATP; 1×ZN;
Assess
SD-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l…
6wjn
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×AGS;
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot…
5vfo
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-240
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
6msd
 Heteromer
O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 2×ADP;
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
6msh
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 3×ATP; 1×ADP;
Assess
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED5_USP14
7w3b
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
3×ATP; 1×ADP; 1×ZN;
Assess
SA-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l…
6wjd
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG48; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×AGS; 5×MG; 2×ADP;
Assess
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED0_USP14
7w3c
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
3×ATP; 2×ADP; 1×ZN;
Assess
Structural basis for dynamic regulation of the human 26S proteasome
5t0g
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
6×ATP; 1×ZN;
Assess
Proteasome-ZFAND5 Complex Z-A state
7qy7
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 5×ATP;
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
6msj
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 4×MG; 1×ADP;
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
6msk
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 1×ADP;
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
6msb
 Heteromer
O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 2×ADP;
Assess
Human PA200-20S proteasome complex
7naq
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; 		2-240
1×IHP;
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot…
5vfu
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN;
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
6msg
 Heteromer
O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 2×ADP; 3×ATP; 3×MG;
Assess
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD4_USP14
7w3k
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
2×ADP; 2×ATP; 1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD5_USP14
7w3m
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
3×ATP; 1×ADP; 1×ZN;
Assess
human PA200-20S complex
6kwy
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; 		2-240
1×K0W; 1×IHP;
Assess
Structure of USP14-bound human 26S proteasome in state EA1_UBL
7w37
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 6×MG; 2×ADP; 1×ZN;
Assess
Structural basis for dynamic regulation of the human 26S proteasome
5t0i
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SB_USP14
7w3i
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 2×ADP; 1×ZN;
Assess
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED1_USP14
7w3f
 Heteromer
A0A087X2I1; O00231; O00232; O00487; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 1×ADP; 1×ZN;
Assess
Structural basis for dynamic regulation of the human 26S proteasome
5t0j
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
4×ATP; 1×ZN;
Assess
Proteasome-ZFAND5 Complex Z+B state
7qxp
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 2×ADP;
Assess
Proteasome-ZFAND5 Complex Z-B state
7qya
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP;
Assess
Proteasome-ZFAND5 Complex Z+E state
7qxx
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 2×ADP;
Assess
Proteasome-ZFAND5 Complex Z+A state
7qxn
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 2×ADP;
Assess
Proteasome-ZFAND5 Complex Z+C state
7qxu
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 2×ADP;
Assess
Proteasome-ZFAND5 Complex Z+D state
7qxw
 Heteromer
O00231; O00232; O00487; O43242; O76080; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 3×ATP; 3×MG; 2×ADP;
Assess
Proteasome-ZFAND5 Complex Z-C state
7qyb
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; 		2-240
1×ZN; 4×ATP; 5×MG; 1×ADP;
Assess
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [(1R)-2-(1-benzofuran-3-yl)-1-{[(1S,2R,4R)-7-ox…
7awe
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; 		2-238
13×NA; 11×SCN; 4×S5K;
Assess
Human Immunoproteasome 20S particle in complex with compound 1
6e5b
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; 		2-238
3×SCN; 12×NA; 4×HUJ;
Assess
Endogeneous native human 20S proteasome
6r70
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-238
Assess
Human 20S proteasome assembly intermediate structure 3
8qym
 Heteromer
O95456; P25786; P25787; P25788; P25789; P28066; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; 		2-238
Assess
Human proteasome 20S core particle
8qyo
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-238
Assess
Akirin2 bound human proteasome
7nht
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q53H80; Q99436; 		2-238
3×K;
Assess
Human PA28-20S (PA28-4a3b)
8cxb
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46; 		2-237
Assess
Human 20S proteasome core particle
7nan
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-237
Assess
Human PA28-20S proteasome complex
7nao
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46; 		2-237
Assess
Human 20S proteasome assembly structure 1
8qyj
 Heteromer
O95456; P25786; P25787; P25788; P25789; P28066; P60900; Q5JS54; Q969U7; Q99436; Q9BT73; Q9Y244; 		6-241
Assess
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin…
7b12
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; 		2-236
5×SO4; 6×NA; 6×SKN;
Assess
Structure of human 20S proteasome with bound MPI-5
7lxv
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-236
2×YHD;
Assess
Human 26S proteasome in complex with Oprozomib
5m32
 Heteromer
O00231; O00232; O00487; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6; 		2-236
6×ADP;
Assess
Human PA28-20S-PA28 proteasome complex
7nap
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46; 		2-236
Assess
Human 20S proteasome assembly intermediate structure 4
8qz9
 Heteromer
O95456; P20618; P25786; P25787; P25788; P25789; P28066; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; 		2-236
Assess
Human preholo proteasome 20S core particle
8qys
 Heteromer
O95456; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; 		3-236
Assess
Human 20S proteasome assembly intermediate structure 5
8qyn
 Heteromer
O95456; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244; 		2-234
Assess
human 20S proteasome
7pg9
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-233
Assess
20S+monoUb-CyclinB1-NT (S1)
7v5g
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-233
Assess
Human 20S Proteasome
6rgq
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-233
Assess
Human 20S proteasome with MG-132
8cvr
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-233
6×LDZ;
Assess
Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively …
6avo
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; 		2-233
2×BZ7;
Assess
20S+monoUb-CyclinB1-NT (S2)
7v5m
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-233
Assess
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core
5a0q
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		5-235
6×KNM;
Assess
Human 20S Proteasome in complex with peptide activator peptide BLM42
8bzl
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; 		2-229
54×CL; 10×MG; 9×1PE; 6×K;
Assess
Human 20S-PA200 Proteasome Complex
6rey
 Heteromer
P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; 		17-234
2×IHP; 2×K0W;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5gjr.22.Amonomer0.822-244
100.00
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26msd.1.Xmonomer0.821-170
100.00
Assess
Isoform 46rgq.1.Rmonomer0.782-143
85.92
Assess